Charité - Universitätsmedizin Berlin

Up-regulated MSI2 is associated with more aggressive chronic myeloid leukemia (2015) Kaeda J, Ringel F, Oberender C, Mills K, Quintarelli C, Pane F, Koschmieder S, et al. Journal article, Original article Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study (2015) Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze S, Schaeffner ES, Mcadams-Demarco M, et al. Journal article Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial (2015) Bader P, Kreyenberg H, Von Stackelberg A, Eckert C, Salzmann-Manrique E, Meisel R, Poetschger U, et al. Journal article Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial (2015) Schetelig J, Schaich M, Schaefer-Eckart K, Haenel M, Aulitzky WE, Einsele H, Schmitz N, et al. Journal article Epilepsy in the elderly: restrictions, fears, and quality of life (2015) May TW, Pfaefflin M, Brandt C, Fueratsch N, Schmitz B, Wandschneider B, Kretz R, et al. Journal article Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI (2015) Wolfsgruber S, Jessen F, Koppara A, Kleineidam L, Schmidtke K, Froelich L, Kurz A, et al. Journal article Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group (2015) Jordan S, Distler J, Maurer B, Huscher D, Van Laar JM, Allanore Y, Distler O Journal article Impact of comorbidities on overall survival in patients with chronic myeloid leukemia: results of the randomized CML study IV (2015) Saussele S, Krauss MP, Hehlmann R, Lauseker M, Proetel U, Kalmanti L, Hanfstein B, et al. Journal article Geographical sequence variation in the Leishmania major virulence factor P46 (2015) Bifeld E, Chrobak M, Zander D, Schleicher U, Schoenian G, Clos J Journal article SWITCH: A Randomised, Sequential, Open-label Study to Evaluate the Efficacy and Safety of Sorafenib-sunitinib Versus Sunitinib-sorafenib in the Treatment of Metastatic Renal Cell Cancer (2015) Eichelberg C, Vervenne WL, De Santis M, Von Weikersthal LF, Goebell P, Lerchenmueller C, Zimmermann U, et al. Journal article